UVIC / Unilens Vision Inc - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

VOTING AGREEMENT

EX-99.1 2 v415562ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VOTING AGREEMENT AGREEMENT, dated as of July 10, 2015, among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”) and Mr. Peter H. Kamin, the beneficial owner of the shares of common stock of Unilens Vision, Inc., a Delaware corporation (the “Company”), listed on Schedule A (the “Stockholder”). W I T N E S S E T H : WHEREAS,

UVIC / Unilens Vision Inc / KAMIN PETER H - FORM SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6) Unilens Vision Inc. (Name of Issuer) Common Stock, $.001 Par Value Per Share (Title of Class of Securities) 904907201 (CUSIP Number) Peter H. Kamin 40 Briarcliff Road Longmeadow, Massachusetts 01106 copy to: Derek D. Bork Thompson Hine LLP 3900 Key Center

UVIC / Unilens Vision Inc 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-17861 UNILENS VISION INC. (Exact name of registra

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 12, 2015 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 27-2254517 (Commission Fi

UNILENS VISION REPORTS HIGHER SALES, ROYALTY INCOME, AND EARNINGS FOR SECOND QUARTER OF FY2015 DILUTED EPS RISE 45% TO $0.29 IN FIRST HALF OF FY2015 VERSUS PRIOR-YEAR PERIOD

EX-99.1 2 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release UNILENS VISION REPORTS HIGHER SALES, ROYALTY INCOME, AND EARNINGS FOR SECOND QUARTER OF FY2015 DILUTED EPS RISE 45% TO $0.29 IN FIRST HALF OF FY2015 VERSUS PRIOR-YEAR PERIOD LARGO, Florida (February 12, 2015) – Unilens Vision Inc. (OTCQX: UVIC), which develops, licenses, manufactures, distributes and markets specialty contact

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) December 17, 2014 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 (Commission File Number)

UVIC / Unilens Vision Inc / KAMIN PETER H Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5 ) Unilens Vision Inc. (Name of Issuer) Common Stock, $.001 Par Value Per Share (Title of Class of Securities) 904907201 (CUSIP Number) Peter H. Kamin One Avery Street, 17B Boston, MA 02111 (Name, Address and Telephone Number of Person Authorized to Receive

UVIC / Unilens Vision Inc / KAMIN PETER H Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4 ) Unilens Vision Inc. (Name of Issuer) Common Stock, $.001 Par Value Per Share (Title of Class of Securities) 904907201 (CUSIP Number) Peter H. Kamin One Avery Street, 17B Boston, MA 02111 (Name, Address and Telephone Number of Person Authorized to Receive

Financial Statements and Exhibits, Other Events

8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 13, 2014 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861

UNILENS VISION REPORTS FIRST QUARTER FY2015 OPERATING RESULTS EPS UP 67% TO $0.15; ROYALTY INCOME RISES 26% FROM PRIOR-YEAR LEVELS

Exhibit 99.1 For Immediate Release UNILENS VISION REPORTS FIRST QUARTER FY2015 OPERATING RESULTS EPS UP 67% TO $0.15; ROYALTY INCOME RISES 26% FROM PRIOR-YEAR LEVELS LARGO, Florida (November 13, 2014) – Unilens Vision Inc. (OTCQX: UVIC), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported operating results for the first quarter of FY2015. First

UVIC / Unilens Vision Inc DEF 14A - - DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ^ ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(

UNILENS VISION REPORTS FOURTH QUARTER AND FY2014 OPERATING RESULTS FOURTH QUARTER EPS UP 220% TO $0.16 ROYALTY INCOME RISES 28% FROM PRIOR-YEAR LEVELS

Exhibit 99.1 For Immediate Release UNILENS VISION REPORTS FOURTH QUARTER AND FY2014 OPERATING RESULTS FOURTH QUARTER EPS UP 220% TO $0.16 ROYALTY INCOME RISES 28% FROM PRIOR-YEAR LEVELS LARGO, Florida (September 29, 2014) – Unilens Vision Inc. (OTCQX:UVIC), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the fourth

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) September 29, 2014 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 27-2254517 (Commission F

UVIC / Unilens Vision Inc / KAMIN PETER H Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3 ) Unilens Vision Inc. (Name of Issuer) Common Stock, $.001 Par Value Per Share (Title of Class of Securities) 904907201 (CUSIP Number) Peter H. Kamin One Avery Street, 17B Boston, MA 02111 (Name, Address and Telephone Number of Person Authorized to Receive

UVIC / Unilens Vision Inc / KAMIN PETER H - PETER H. KAMIN / UNILENS VISION, INC. Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2 ) Unilens Vision Inc. (Name of Issuer) Common Stock, $.001 Par Value Per Share (Title of Class of Securities) 904907201 (CUSIP Number) Peter H. Kamin One Avery Street, 17B Boston, MA 02111 (Name, Address and Telephone Number of Person Authorized to Receive

UNILENS VISION INC. REPORTS 87% INCREASE IN THIRD QUARTER DILUTED EARNINGS PER SHARE ROYALTY INCOME RISES 13% FROM PRIOR-YEAR LEVELS

Exhibit 99.1 For Immediate Release UNILENS VISION INC. REPORTS 87% INCREASE IN THIRD QUARTER DILUTED EARNINGS PER SHARE ROYALTY INCOME RISES 13% FROM PRIOR-YEAR LEVELS LARGO, Florida (May 15, 2014) – Unilens Vision Inc. (OTCQB: UVIC), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the third quarter and first nine m

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 15, 2014 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 27-2254517 (Commission File Nu

UVIC / Unilens Vision Inc / KAMIN PETER H Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 ) Unilens Vision Inc. (Name of Issuer) Common Stock, $.001 Par Value Per Share (Title of Class of Securities) 904907201 (CUSIP Number) Peter H. Kamin One Avery Street, 17B Boston, MA 02111 (Name, Address and Telephone Number of Person Authorized to Receive

Financial Statements and Exhibits, Other Events

8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 14, 2014 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861

UNILENS VISION INC. REPORTS OPERATING RESULTS FOR SECOND QUARTER OF FY2014 ROYALTY INCOME INCREASES FOR FIRST TIME IN SIX QUARTERS

EX-99 2 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release UNILENS VISION INC. REPORTS OPERATING RESULTS FOR SECOND QUARTER OF FY2014 ROYALTY INCOME INCREASES FOR FIRST TIME IN SIX QUARTERS LARGO, Florida (February 14, 2014) – Unilens Vision Inc. (OTCQB: UVIC), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results

Submission of Matters to a Vote of Security Holders - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) December 18, 2013 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 (Commission File Number)

Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 14, 2013 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 (Commission File Number)

UNILENS VISION INC. REPORTS OPERATING RESULTS FOR FIRST QUARTER OF FY2014

EX-99 2 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release UNILENS VISION INC. REPORTS OPERATING RESULTS FOR FIRST QUARTER OF FY2014 LARGO, Florida (November 14, 2013) – Unilens Vision Inc. (OTCQB: UVIC), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the first quarter of FY2014. Highlights of Quarter E

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ^ ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(

UVIC / Unilens Vision Inc / KAMIN PETER H Activist Investment

SC 13D 1 eps5309.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) Unilens Vision Inc. (Name of Issuer) Common Stock, $.001 Par Value Per Share (Title of Class of Securities) 904907201 (CUSIP Number) Peter H. Kamin One Avery Street, 17B Boston, MA 02111 (Name, Address and Telephone Number of Person Au

UVIC / Unilens Vision Inc / Baker Street Capital Management, LLC - AMENDMENT NO. 7 TO THE SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 7)1 Unilens Vision Inc. (Name of Issuer) Common Stock, $.001 Par Value Per Share (Title of Class of Securities) 904907201 (CUSIP Number) VADIM PERELMAN BAK

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) October 4, 2013 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 27-2254517 (Commission File

Exhibit 10.3

EX-10 4 exhibit103.htm EXHIBIT 10.3 Exhibit 10.3 Hancock Bank Commercial Revolving Line of Credit Note Wilmington, Delaware $750,000.00 October 3, 2013 For value received, the undersigned maker(s) (hereinafter referred to as "Borrower", which term means individually, collectively, and interchangeably any, each and/or all of them), jointly and severally, promises to pay to the order of HANCOCK BANK

STOCK PURCHASE AGREEMENT

Exhibit 99.1 STOCK PURCHASE AGREEMENT AGREEMENT, dated as of October 4, 2013, between UNILENS VISION INC., a Delaware corporation (“Buyer”), and BAKER STREET CAPITAL L.P., a Delaware limited partnership (“Seller”). W I T N E S S E T H WHEREAS, Seller owns 618,522 shares of the Common Stock, par value $0.01 per share of Buyer (the “Shares”); WHEREAS, Buyer wishes to purchase, and Seller wishes to s

STOCK PURCHASE AGREEMENT

Exhibit 10.5 STOCK PURCHASE AGREEMENT AGREEMENT, dated as of October 4, 2013, between UNILENS VISION INC., a Delaware corporation (“Buyer”), and BAKER STREET CAPITAL L.P., a Delaware limited partnership (“Seller”). W I T N E S S E T H WHEREAS, Seller owns 618,522 shares of the Common Stock, par value $0.01 per share of Buyer (the “Shares”); WHEREAS, Buyer wishes to purchase, and Seller wishes to s

Exhibit 10.2

Exhibit 10.2 Hancock Bank Commercial Term Note Wilmington, Delaware $5,785,457.50 October 3, 2013 For value received, the undersigned maker(s) (hereinafter referred to as "Borrower", which term means individually, collectively, and interchangeably any, each and/or all of them), jointly and severally, promises to pay to the order of HANCOCK BANK, a Mississippi state chartered bank ("Bank") with an

UNILENS VISION ANNOUNCES STOCK REPURCHASE AND DIRECTOR RESIGNATION 26 % REDUCTION IN SHARES OUTSTANDING IS ACCRETIVE TO EPS

EX-99 7 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release UNILENS VISION ANNOUNCES STOCK REPURCHASE AND DIRECTOR RESIGNATION 26 % REDUCTION IN SHARES OUTSTANDING IS ACCRETIVE TO EPS LARGO, Florida (October 4, 2013) – Unilens Vision Inc. (OTCQB: UVIC), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced that the Company has repurcha

LOAN MODIFICATION AND EXTENSION AGREEMENT

Exhibit 10.4 LOAN MODIFICATION AND EXTENSION AGREEMENT THIS LOAN MODIFICATION AND EXTENSION AGREEMENT (the “Agreement”) is entered into as of the 3rd day of October, 2013,by and between HANCOCK BANK, a Mississippi state chartered bank (“Lender”), UNILENS CORP. USA, a Delaware corporation (“Unilens”), and UNILENS VISION SCIENCES INC., a Delaware corporation (“UVSI”) (Unilens and UVSI, jointly and s

Exhibit 10.1

EX-10 2 exhibit101.htm EXHIBIT 10.1 Exhibit 10.1 AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT between HANCOCK BANK, a Mississippi state chartered bank, “Lender” and UNILENS CORP. USA, a Delaware corporation UNILENS VISION SCIENCES INC., a Delaware corporation (collectively the “Borrower”) UNILENS VISION INC., a Delaware corporation (the “Guarantor”) Dated as of October 3, 2013 TABLE OF CONTE

Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) September 27, 2013 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 27-2254517 (Commission F

UNILENS VISION TO VOLUNTARILY DELIST COMMON STOCK FROM TSX VENTURE EXCHANGE

EX-99 2 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release UNILENS VISION TO VOLUNTARILY DELIST COMMON STOCK FROM TSX VENTURE EXCHANGE LARGO, Florida (September 27, 2013) – Unilens Vision Inc. (OTCQB: UVIC) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced that it has applied for and received approval

UNILENS VISION REPORTS FOURTH QUARTER AND FY2013 OPERATING RESULTS

EX-99 2 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release UNILENS VISION REPORTS FOURTH QUARTER AND FY2013 OPERATING RESULTS LARGO, Florida (September 30, 2013) – Unilens Vision Inc. (OTCQB: UVIC) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the quarter and fiscal year en

Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) September 30, 2013 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 27-2254517 (Commission F

UNILENS VISION REPORTS THIRD QUARTER OPERATING RESULTS

EX-99.1 2 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release UNILENS VISION REPORTS THIRD QUARTER OPERATING RESULTS LARGO, Florida (May 15, 2013) – Unilens Vision Inc. (OTCQB: UVIC) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the third quarter and first nine months of FY2

Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported May 15, 2013 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 (Commission File Number) 27-225

Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 11, 2013 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 (Commission File Number) 27-

UNILENS MODIFIES LICENSE AGREEMENT WITH BAUSCH + LOMB - GRANTS RIGHT TO USE NEXT GENERATION MULTIFOCAL TECHNOLOGY

Exhibit 99.1 For Immediate Release UNILENS MODIFIES LICENSE AGREEMENT WITH BAUSCH + LOMB - GRANTS RIGHT TO USE NEXT GENERATION MULTIFOCAL TECHNOLOGY LARGO, Florida (April 11, 2013) – Unilens Vision Inc. (OTC Markets Group OTCQB: UVIC) (TSX Venture Exchange: UVI), through it’s wholly owned subsidiary Unilens Vision Sciences Inc. today announced that the company and Bausch + Lomb have extended the p

Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 14, 2013 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 (Commission File Number)

UNILENS VISION REPORTS SECOND QUARTER OPERATING RESULTS CUSTOM SOFT LENS SALES INCREASE 11% FROM PRIOR-YEAR LEVELS

Exhibit 99.1 For Immediate Release UNILENS VISION REPORTS SECOND QUARTER OPERATING RESULTS CUSTOM SOFT LENS SALES INCREASE 11% FROM PRIOR-YEAR LEVELS LARGO, Florida (February 14, 2013) – Unilens Vision Inc. (OTCQB: UVIC) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the second quarter

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - FORM 8-K

uvic8kjan201311.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) January 8, 2013 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Juri

/s/ Pender Newkirk and Company LLP

EX-16 2 exhibit161.htm EXHIBIT 16.1 Exhibit 16.1 Letter from Independent Registered Public Accounting Firm Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Commissioners: We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred January1, 2013, to be filed by our client, Unilens Vision Inc. We do not disagree with the statem

UVIC / Unilens Vision Inc / KAMIN PETER H Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* UNILENS VISION INC. (Name of Issuer) Common Stock, $.001 par value (Title of Class of Securities) 904907201 (CUSIP Number) January 10, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t

Submission of Matters to a Vote of Security Holders - FORM 8-K

form8k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 15, 2012 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdictio

EX-99

EX-99 2 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release UNILENS VISION REPORTS FIRST QUARTER OPERATING RESULTS CUSTOM SOFT LENS SALES INCREASE 15.6% FROM PRIOR-YEAR LEVELS LARGO, Florida (November 14, 2012) – Unilens Vision Inc. (OTCQB: UVIC) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its oper

Financial Statements and Exhibits, Other Events - FORM 8-K

kforpressreleasenov142012uni.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 14, 2012 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (Stat

- DEF 14A

def14a.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ^ ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) September 28, 2012 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 27-2254517 (Commission F

EX-99

EX-99 2 exhibit99.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release UNILENS VISION REPORTS FY2012 OPERATING RESULTS CUSTOM SOFT LENS SALES INCREASE 31% FROM PRIOR-YEAR LEVELS LARGO, Florida (September 28, 2012) – Unilens Vision Inc. (OTCQB: UVIC) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating res

Commercial Revolving Line of Credit Note Wilmington, Delaware $1,500,000.00 May 17, 2012

exhibit10z3.htm - Generated by SEC Publisher for SEC Filing Exhibit 10.3 Commercial Revolving Line of Credit Note Wilmington, Delaware $1,500,000.00 May 17, 2012 For value received, the undersigned maker(s) (hereinafter referred to as "Borrower", which term means individually, collectively, and interchangeably any, each and/or all of them), jointly and severally, promises to pay to the order of HA

1. GUARANTEED OBLIGATIONS. Guarantor jointly, severally and unconditionally guarantees to Bank the prompt payment in full of all obligations and liabilities of Borrower to Bank, direct or contingent, due or to become due, now existing or hereafter ar

exhibit10z5.htm - Generated by SEC Publisher for SEC Filing Exhibit 10.5 Continuing Guaranty The undersigned (hereinafter sometimes referred to as “Guarantor,” which term means individually, collectively, and interchangeably any, each and/or all of them) hereby gives to HANCOCK BANK, a Mississippi state chartered bank, with an office located at 100 Second Avenue North, Suite 200, St. Petersburg, F

1. Assignment. In consideration of Ten and No/100 Dollars ($10.00) and for other good, valuable, and sufficient consideration, the receipt of which is hereby acknowledged by Grantor, and to secure the above-described obligations, Grantor does hereby

EX-10 5 exhibit10z4.htm EXHIBIT 10.4 Exhibit 10.4 PATENT SECURITY AGREEMENT THIS PATENT SECURITY AGREEMENT (this “Agreement”) is made May 17, 2012, by UNILENS CORP. USA, a Delaware corporation (“Grantor”), having an address of Nemours Building, 1007 Orange Street, Suite 1410, Wilmington, Delaware 19801 in favor of HANCOCK BANK, a Mississippi state chartered bank (“Grantee”), having an address of 1

Exhibit 99.1 For Immediate Release UNILENS VISION INC. REFINANCES BANK DEBT ON MORE ATTRACTIVE TERMS WITH HANCOCK BANK “We are very pleased to announce our new banking relationship with Hancock Bank,” stated Michael Pecora, Chief Executive Officer of

EX-99 7 exhibit99z1.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release UNILENS VISION INC. REFINANCES BANK DEBT ON MORE ATTRACTIVE TERMS WITH HANCOCK BANK REFINANCED TERM LOAN AND REVOLVING CREDIT FACILITY PROVIDE COMPANY WITH GREATER FLEXIBILITY LARGO, Florida (May 24, 2012) – Unilens Vision Inc. (OTCBB: UVIC) (OTCQB: UVIC) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, dis

Commercial Term Note Wilmington, Delaware $3,500,000.00 May 17, 2012

EX-10 3 exhibit10z2.htm EXHIBIT 10.2 Exhibit 10.2 Commercial Term Note Wilmington, Delaware $3,500,000.00 May 17, 2012 For value received, the undersigned maker(s) (hereinafter referred to as "Borrower", which term means individually, collectively, and interchangeably any, each and/or all of them), jointly and severally, promises to pay to the order of HANCOCK BANK, a Mississippi state chartered b

1. GENERAL DEFINITIONS. 2. REVOLVING CREDIT FACILITY. 3. TERM LOAN AND MERCHANT LOAN. 4. CONDITIONS PRECEDENT. 5. FEES. 6. DEFAULT RATE; MAXIMUM RATE; OTHER PAYMENT TERMS. 7. COLLATERAL: GENERAL TERMS. 8. WARRANTIES AND REPRESENTATIONS. 9. COVENANTS

exhibit101.htm - Generated by SEC Publisher for SEC Filing Exhibit 10.1 CREDIT AND SECURITY AGREEMENT between HANCOCK BANK, a Mississippi state chartered bank, “Lender” and UNILENS CORP. USA, a Delaware corporation UNILENS VISION SCIENCES INC., a Delaware corporation (collectively the “Borrower”) UNILENS VISION INC., a Delaware corporation (the “Guarantor”) Dated as of May 17, 2012 TABLE OF CONTEN

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 23, 2012 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 000-17861 (Commission File Number) 27-22

Exhibit 99.1 For Immediate Release UNILENS VISION REPORTS DILUTED EPS OF $0.13 FOR THIRD QUARTER OF FY2012

exhibit99z1.htm - Generated by SEC Publisher for SEC Filing Exhibit 99.1 For Immediate Release UNILENS VISION REPORTS DILUTED EPS OF $0.13 FOR THIRD QUARTER OF FY2012 CUSTOM SOFT LENS SALES INCREASE 26% FROM PRIOR-YEAR QUARTER LARGO, Florida (May 15, 2012) – Unilens Vision Inc. (OTC Markets Group OTCQB: UVIC) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and mark

Financial Statements and Exhibits, Other Events

uvi8k051520121.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 15, 2012 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdic

Financial Statements and Exhibits, Other Events - FORM 8-K

uvi8kdoc2142012.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 14, 2012 Unilens Vision Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Ju

For Immediate Release UNILENS VISION REPORTS DILUTED EPS OF $0.12 FOR SECOND QUARTER OF FY2012

EX-99 2 exhibit99z1.htm EXHIBIT 99.1 Exhibit 99.1 For Immediate Release UNILENS VISION REPORTS DILUTED EPS OF $0.12 FOR SECOND QUARTER OF FY2012 CUSTOM SOFT LENS SALES INCREASE 43.3% FROM PRIOR-YEAR QUARTER LARGO, Florida (February 14, 2012) – Unilens Vision Inc. (OTC Markets Group OTCQB: UVIC) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty c

UVIC / Unilens Vision Inc / KAMIN PETER H - PETER H. KAMIN / UNILENS VISION INC. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* UNILENS VISION INC. (Name of Issuer) Common Stock, $.001 par value (Title of Class of Securities) 904907201 (CUSIP Number) February 9, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t